Browse Health


Education ?

Medical School Score
Louisiana State University at New Orleans (2001)

Awards & Distinctions ?

Patients' Choice Award (2008 - 2009, 2014 - 2015)
Compassionate Doctor Recognition (2009, 2014 - 2015)
American Board of Urology
American Urological Association

Affiliations ?

Dr. Simoneaux is affiliated with 3 hospitals.

Hospital Affiliations



  • Thibodaux Regional Medical Center
    PO Box 1118, Thibodaux, LA 70302
    Top 50%
  • Teche Regional Medical Center
    1125 Marguerite St, Morgan City, LA 70380
  • Terrebonne General Medical Center
  • Publications & Research

    Dr. Simoneaux has contributed to 4 publications.
    Title Incidence and Management of Vaginal Extrusion of Acellular Porcine Dermis After Incontinence and Prolapse Surgery.
    Date January 2008
    Journal International Urogynecology Journal and Pelvic Floor Dysfunction

    We report our experience with vaginal extrusion of acellular porcine dermis in women undergoing pelvic reconstructive surgery. Over 5 years, 270 patients received a Pelvicol pubovaginal sling (PVS) or prolapse repair using interposition graft. Charts were retrospectively evaluated for evidence of graft extrusion, management, and outcomes. Chi-square analysis was conducted to evaluate the association of extrusion with perioperative variables. Nineteen women (7%) had partial or complete vaginal graft extrusion. After a PVS, 11 of 13 women healed by re-epithelialization and remained continent, while 2 required operative debridement. Four of six patients receiving interposition grafts healed after small incisional separations. Two women underwent additional surgery to address extensive extrusion, and both prolapses recurred. After statistical analysis, vaginal extrusion was significantly associated with PVS and concomitant urethral diverticulectomy. Small incisional separations frequently heal and cause no symptom recurrence. Larger areas of extrusion may require debridement and may contribute to recurrence of symptoms.

    Title African-american Race is a Predictor of Prostate Cancer Detection: Incorporation into a Pre-biopsy Nomogram.
    Date October 2006
    Journal Bju International

    OBJECTIVES: To construct a pre-biopsy predictive model incorporating several clinical variables, including African-American (AA) or Caucasian race, to predict the risk of prostate cancer detection on prostate biopsy, as traditionally AA men have had a higher incidence of prostate cancer than Caucasian men, but previous predictive tools for prostate cancer have not incorporated the effect of race. PATIENTS AND METHODS: We evaluated 9473 patients undergoing initial prostate biopsy at three equal-access healthcare institutes from 1993 to 2003. At each biopsy session, patient age, race, serum prostate-specific antigen level (PSA), digital rectal examination (DRE) findings, number of biopsy cores taken, year of biopsy, and pathological findings were recorded. A logistic regression model was constructed to evaluate predictors of cancer detection based on pre-biopsy variables. The model was internally validated using the bootstrap statistical method, and a nomogram was constructed. RESULTS: Prostate cancer was diagnosed in 1895 (33%) AA men and 991 (26%) Caucasians. AA men had a significantly higher mean serum PSA level than Caucasians, at 13.0 and 8.5 ng/mL, respectively (P < 0.001). The mean ages were similar between AA and Caucasian men (P = 0.23), but Caucasian men had a higher incidence of an abnormal DRE (P < 0.001). On multivariate analysis, age, race, year of biopsy, PSA level, DRE, and number of cores taken were all statistically significant (P < 0.001). Hazard ratios were (controlling for year of biopsy); age (1.30), Caucasian race (0.74), PSA level (1.47), DRE (1.75), and number of cores taken (1.19). The predicted model had a boot-strapped concordance index of 0.75. CONCLUSION: AA race remains an independent predictor of prostate cancer detection in men undergoing initial prostate biopsy. This nomogram is the first to individualise the risk by AA or Caucasian race in a predictive model for counselling men on their probability of having cancer at the time of their first biopsy.

    Title Pathology Case of the Month. Young Woman with Abdominal Pain and a Right Upper Quadrant Mass. Papillary Renal Cell Carcinoma, Type 2.
    Date July 2006
    Journal The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society
    Title Race is Not a Predictor of Prostate Cancer Detection on Repeat Prostate Biopsy.
    Date January 2005
    Journal The Journal of Urology

    PURPOSE: We evaluated men undergoing repeat prostate biopsies for persistently increased serum prostate specific antigen (PSA) levels to determine if race was a predictor of cancer detection. MATERIALS AND METHODS: Between July 1995 and June 2002, 401 men had undergone 2 or more transrectal ultrasound guided prostate biopsies at our institutions. Clinical information was gathered using our prostate biopsy database and retrospectively reviewed. Race, age, serum PSA, PSA velocity, total number of biopsies performed, total number of previous negative cores and the presence of high grade prostatic intraepithelial neoplasia (HGPIN) or atypical small acinar proliferation (ASAP) on prior biopsy were evaluated to determine if they were predictors of subsequent cancer detection. Multivariate analysis was performed using a time dependent covariate Cox proportional hazards model. RESULTS: Of the 401 men undergoing repeat prostate biopsy, 91 (22.7%) were diagnosed with prostate cancer. In total there were 180 (44.9%) black men and 221 (55.1%) white men. Cancer was diagnosed in 49 black men (27.2%) and 42 white men (19.0%, p = 0.06). On multivariate analysis serum PSA, HGPIN, ASAP and PSA velocity were predictors of prostate cancer detection (p = 0.006, <0.0001, 0.001 and 0.0004, respectively). Race was not found to be a predictor of prostate cancer detection on repeat prostate biopsy (p = 0.16). In the evaluation of clinical data for racial differences, black men had a significantly higher incidence of HGPIN on prior biopsy compared to white men (p = 0.02). Serum PSA, PSA velocity, presence of ASAP on prior biopsy, age, number of biopsies performed and number of previous negative cores were not statistically different between black and white men. CONCLUSIONS: Race is not a predictor of prostate cancer detection in men undergoing repeat prostate biopsies. With the exception of HGPIN, all other clinical parameters were similar between black and white men. Serum PSA, PSA velocity, HGPIN and ASAP were found to be significant predictors of subsequent prostate cancer detection.

    Similar doctors nearby

    Dr. P Ray

    36 years experience
    Thibodaux, LA

    Dr. Chester Weimer

    36 years experience
    Thibodaux, LA

    Dr. James Leonard

    49 years experience
    Thibodaux, LA

    Dr. Koti Sangisetty

    37 years experience
    Houma, LA

    Dr. Frank Graffagnino

    50 years experience
    Houma, LA

    Dr. Haden Lafaye

    22 years experience
    Houma, LA
    Search All Similar Doctors